Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GDX vs MRNA✓SelectedUSD · MRNAGDX vs MRNA performance historyLatest closeAs of+0.79%11/17
Stock and ETF performance explorer

GDX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+149.1%
MRNA return
-16.0%
Excess return
+165.0%
Maximum drawdown
-46.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.8%-3.9%+4.7%+1.1%
7D-8.0%-17.6%+9.6%-6.6%
30D-9.3%-5.1%-4.1%-9.0%
3M-13.4%+220.8%-234.2%-25.3%
6M-8.9%+321.7%-330.6%-23.8%
YTD-7.2%+601.3%-608.5%-25.9%
1Y+6.9%+735.2%-728.3%-15.9%
3Y+189.9%+170.5%+19.4%+140.9%
All+149.1%-16.0%+165.0%+119.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling